@article{2e229f096bd545b4ac6dd1b7a9e0fa5c,
title = "Observations regarding the immunogenicity of BDD-rFVIII derived from a mechanistic personalized medicine perspective",
author = "Sauna, {Z. E.} and A. Ameri and B. Kim and C. Yanover and Viel, {K. R.} and R. Rajalingam and Cole, {S. A.} and Howard, {T. E.}",
note = "Funding Information: The authors would also like to thank V. La Terza, C. Kasper and J. Lusher for helpful discussions and technical editing during the preparation of this manuscript. Research conducted in the laboratory of ZES is funded by the modernization of science program of the Center for Biologics Evaluation and Research, Food and Drug Administration. Research conducted in the laboratory of TEH is funded by grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health (1RC2‐HL101851, HL‐71130 and HL‐72533) as well as from the: Bayer Healthcare Corporation, Bayer Hemophilia Awards Program and Baxter Healthcare Corporation.",
year = "2012",
month = sep,
doi = "10.1111/j.1538-7836.2012.04830.x",
language = "English (US)",
volume = "10",
pages = "1961--1965",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
publisher = "Wiley-Blackwell",
number = "9",
}